Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic

Jinah Choi1

  • 1Department of Molecular Cell Biology, School of Natural Sciences, University of California at Merced, Merced, CA 95343, USA. jchoi@ucmerced.edu

Insights

Hepatitis C virus (HCV) infection causes significant oxidative stress, increasing risks for liver damage and cancer. Alcohol consumption worsens these effects, impacting viral resistance and treatment outcomes.

Area of Science:

  • Hepatology
  • Virology
  • Biochemistry

Background:

  • Hepatitis C virus (HCV) is a global health concern, causing chronic infections in a majority of cases.
  • Chronic HCV infection is linked to severe liver conditions like steatosis, cirrhosis, and hepatocellular carcinoma.
  • HCV pathogenesis involves significant oxidative and nitrosative stress, impacting both hepatic and extrahepatic tissues.

Purpose of the Study:

  • To review the current understanding of redox interactions in Hepatitis C virus infection.
  • To outline key experimental findings on oxidative stress in HCV pathogenesis.
  • To identify future research directions and potential therapeutic applications.

Main Methods:

  • Review of existing clinical, animal, and in vitro studies.
  • Analysis of the sources and effects of oxidative/nitrosative stress induced by HCV.
  • Examination of the role of alcohol in exacerbating HCV-related oxidative stress and pathogenesis.

Main Results:

  • HCV induces oxidative/nitrosative stress through various pathways, including NOS, mitochondria, and NADPH oxidases, while depleting glutathione.
  • This oxidative burden contributes to HCV-induced hepatic and extrahepatic conditions.
  • Alcohol exacerbates HCV-induced oxidative stress and hepatopathogenesis, potentially influencing immune response, viral replication, and antiviral resistance.

Conclusions:

  • Oxidative/nitrosative stress is a critical factor in Hepatitis C virus pathogenesis.
  • Alcohol significantly worsens the oxidative burden and associated complications in HCV patients.
  • Further research into redox interactions may lead to novel therapeutic strategies for HCV.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...